EUFOREA Rhinology Future Debates 2017
Novel Treatments and Surgical Solutions in Rhinology
The Rhinology Future Debates is a unique clinician-orientated initiative organised by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA). EUFOREA (www.euforea.eu) is an international non-profit organisation aiming at reducing the prevalence and burden of chronic respiratory diseases. EUFOREA brings together specialists from the entire healthcare system to create opportunities for innovative thinking and the development of new techniques, devices, protocols and concepts for a patient-centred approach to prevention and optimal care.1 Advocacy for integrated care pathways and implementation of precision medicine in respiratory diseases are key priorities of the EUFOREA team.
The Rhinology Future Debates have been organised for the first time in 2016 and aim at filling the gap between industry-investor meetings and clinicians working with patients affected by upper respiratory diseases. The debates deal with topics of innovation in diagnostic and therapeutic approaches, including novel devices, molecules, e-health tools and other innovative solutions.
The second Rhinology Future Debate took place in Brussels in December 2017 and brought together key experts in the field of respiratory diseases, industrial partners and patients for a discussion forum in the respiratory field. Debate topics in 2017 included Real World Evidence data in AIT—What does it bring to us?, Positioning Dymista in Allergic Rhinitis treatment (a separate report is available for this debate), Nasal turbinate as a therapeutic target in patients with turbinate-induced nasal symptoms, and Lessons from biologicals in asthma for ENT physicians.
Co-Authors:Â Wytske Fokkens, Benoit Pugin, Claus Bachert, Jean Bousquet, Guy Joos, Renaud Louis, Charles Pilette, Oliver Pfaar, David Price, Emmanuel Prokopakis, Glenis Scadding, Agnieszka Strzembosz, Anders Weilandt, Sven Seys and Peter Hellings.
